| Literature DB >> 27373493 |
Brian J Liddicoat1, Jochen C Hartner2, Robert Piskol3, Gokul Ramaswami3, Alistair M Chalk1, Paul D Kingsley4, Vijay G Sankaran5, Meaghan Wall6, Louise E Purton1, Peter H Seeburg7, James Palis4, Stuart H Orkin8, Jun Lu9, Jin Billy Li3, Carl R Walkley10.
Abstract
Adenosine deaminases that act on RNA (ADARs) convert adenosine residues to inosine in double-stranded RNA. In vivo, ADAR1 is essential for the maintenance of hematopoietic stem/progenitors. Whether other hematopoietic cell types also require ADAR1 has not been assessed. Using erythroid- and myeloid-restricted deletion of Adar1, we demonstrate that ADAR1 is dispensable for myelopoiesis but is essential for normal erythropoiesis. Adar1-deficient erythroid cells display a profound activation of innate immune signaling and high levels of cell death. No changes in microRNA levels were found in ADAR1-deficient erythroid cells. Using an editing-deficient allele, we demonstrate that RNA editing is the essential function of ADAR1 during erythropoiesis. Mapping of adenosine-to-inosine editing in purified erythroid cells identified clusters of hyperedited adenosines located in long 3'-untranslated regions of erythroid-specific transcripts and these are ADAR1-specific editing events. ADAR1-mediated RNA editing is essential for normal erythropoiesis.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27373493 PMCID: PMC5035604 DOI: 10.1016/j.exphem.2016.06.250
Source DB: PubMed Journal: Exp Hematol ISSN: 0301-472X Impact factor: 3.084